Adefovir dipivoxil nella terapia dell’epatite B cronica: profilo farmacologico clinico ed economico
Despite the fact that an effective vaccine against hepatitis B virus (HBV) has been available for over 30 years, the worldwide prevalence of this infection is still very high. Until recently, there were only two effective therapeutic options for chronic hepatitis B (CHB), interferon and lamivudine,...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2005-12-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/849 |